Sustained Virologic Suppression Reduces HIV-1 DNA Proviral Levels and HIV Antibodies in Perinatally HIV-Infected Children Followed from Birth
Trevon Fuller(University of California, Los Angeles), Karin Nielsen‐Saines(University of California, Los Angeles), Tara Kerin(University of California, Los Angeles), Ruth Cortado(University of California, Los Angeles), Myung Shin-Sim(Saint John's Health Center), Ivete Gomes(Universidade Iguaçu), Priya R. Soni(Cedars-Sinai Medical Center), Tauí de Melo Rocha(Hospital Nossa Senhora da Conceição), Christianne Moreira(Hospital Federal dos Servidores do Estado), José Henrique Pilotto(Universidade Iguaçu), Esaú João(Hospital Federal dos Servidores do Estado), Maria Isabel Fragoso da Silveira Fragoso da Silveira Gouvêa(Hospital Federal dos Servidores do Estado), Maria Letícia Santos Cruz(Hospital Federal dos Servidores do Estado), Yvonne J. Bryson(Oklahoma State University Center for Health Sciences), Maria de Lourdes Benamor Teixeira(Hospital Federal dos Servidores do Estado), Breno Santos(Hospital Nossa Senhora da Conceição)
Cited by 1
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
|New England Journal of Medicine|2011|541
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
|The Lancet Infectious Diseases|2014|513
Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome
|New England Journal of Medicine|2002|347